International Conference on Cardiac Biomarkers and Genetics

This track focuses on the mechanisms of cardiac electrophysiology and their implications for heart function. Researchers are invited to present findings related to arrhythmias, conduction abnormalities, and innovative electrophysiological interventions.

This session will explore the genetic underpinnings of various cardiac conditions, including familial cardiomyopathies and inherited arrhythmias. Contributions that elucidate the role of genetic markers in disease susceptibility and progression are encouraged.

This track aims to discuss the latest advancements in cardiac biomarkers and their application in clinical settings. Presentations should focus on the diagnostic and prognostic value of biomarkers in heart disease management.

This session will delve into the pathophysiology, epidemiology, and treatment strategies for atrial fibrillation. Researchers are invited to share innovative approaches to prevention, diagnosis, and therapeutic interventions.

This track will highlight cutting-edge techniques in cardiac surgery, including minimally invasive procedures and robotic-assisted surgeries. Contributions that discuss outcomes, challenges, and advancements in surgical methodologies are welcome.

This session will focus on the etiology and management of ischemic heart disease, including coronary artery disease and myocardial infarction. Presentations should address novel therapeutic strategies and the role of cardiac rehabilitation.

This track is dedicated to the unique challenges and advancements in pediatric cardiovascular surgery. Researchers are encouraged to present studies on surgical techniques, outcomes, and long-term care for congenital heart defects.

This session will explore the latest research on heart valve disorders, including stenosis and regurgitation. Contributions that discuss innovative repair techniques and replacement strategies are particularly encouraged.

This track will investigate the relationship between cardiac health and cancer, focusing on the cardiovascular implications of cancer therapies. Presentations should address both the prevention and management of cardiac complications in cancer patients.

This session will focus on the latest developments in heart transplantation and the management of advanced heart failure. Researchers are invited to discuss donor selection, immunosuppression strategies, and post-transplant outcomes.

This track will highlight the role of emerging technologies in the field of cardiology, including telemedicine, wearable devices, and artificial intelligence. Contributions that explore the integration of these technologies into clinical practice are encouraged.